Related Experiment Video
Updated: Jun 22, 2026
08:44
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Regulatory T cells and EBV associated malignancies
Jiang Li1, Chao-Nan Qian, Yi-Xin Zeng
1State Key Laboratory of Oncology in South China, PR China.
International Immunopharmacology
|June 23, 2009
Summary
T-regulatory cells (Tregs) suppress anti-tumor immunity in Epstein-Barr virus (EBV)-positive cancers, hindering effective adoptive T-cell immunotherapy. Targeting Tregs may improve cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- T-regulatory cells (Tregs) are crucial for immune tolerance but also impede anti-tumor immunity.
- Cytotoxicity T cells (CTLs) show potential against EBV-positive tumors (e.g., HL, NPC) by recognizing viral antigens.
- Current CTL adoptive immunotherapy for EBV-positive cancers yields limited clinical benefits, with Tregs identified as a major obstacle.
Purpose of the Study:
- To review the relationship between EBV antigen expression and Treg induction in the tumor microenvironment.
- To explore Treg subsets and their mechanisms in suppressing anti-tumor immunity in EBV-associated malignancies.
- To discuss potential strategies for targeting Tregs in future immunotherapies for EBV-positive cancers.
Main Methods:
- Literature review and synthesis of existing research on Tregs, EBV, and anti-tumor immunity.
- Analysis of the role of EBV antigens in Treg induction within the tumor microenvironment.
- Discussion of Treg subsets and their immunosuppressive functions in EBV-associated cancers.
Main Results:
- EBV antigen expression on tumor cells correlates with Treg induction in the tumor microenvironment.
- Tregs, through various subsets and mechanisms, significantly attenuate anti-tumor immunity.
- Tregs represent a critical barrier to the efficacy of CTL adoptive immunotherapy in EBV-positive malignancies.
Conclusions:
- Tregs play a pivotal role in immune evasion within EBV-associated cancers.
- Understanding Treg-mediated suppression is essential for developing effective immunotherapies.
- Targeting Tregs offers a promising strategy to enhance the efficacy of adoptive T-cell therapy for EBV-positive cancers.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...